IPP Bureau
Endimension receives Rs 2.3 crore in seed funding
By IPP Bureau - September 23, 2021
The startup’s AI platform uses AI algorithms to automatically detect abnormalities and diseases in medical images, reducing patient misdiagnosis and increasing radiologists’ productivity
Indian Pharma Market growth stable in August 2021
By IPP Bureau - September 23, 2021
Post normalisation of high growth months of April and May this year the average IPM growth from June to August this year stood at 15.2 % YoY : Ind-Ra reports
MergerDomo facilitates fundraising for health food and wellness startups
By IPP Bureau - September 22, 2021
The two startups will utilise the capital for business growth including strategic expansion, product development, R&D and technology investments
.jpg "Terumo India releases stamp to commemorate the centenary of Terumo Corporation")
Terumo India releases stamp to commemorate the centenary of Terumo Corporation
By IPP Bureau - September 22, 2021
Terumo’s first product was the domestically produced, safe, high-quality thermometer. The company has since supported the healthcare ecosystem worldwide
Boehringer Ingelheim acquires Abexxa Biologics to advance its cancer research
By IPP Bureau - September 22, 2021
The addition of Abexxa’s expertise complements Boehringer Ingelheim’s current approaches to the treatment of difficult-to-treat solid cancers and especially those resistant to available immunotherapies
SCHOTT expands tubing capacity in India
By IPP Bureau - September 22, 2021
In India, almost all approved vaccines are packed in FIOLAX glass made by SCHOTT
Trialbee and Castor partner to simplify enrolment to clinical trials globally
By IPP Bureau - September 22, 2021
Industry leaders to increase patient access to clinical research and scale remote enrollment of participants for trial sponsors to promote increased health equity
DCGI approves Ampio Pharma’s Phase II trials to tackle Covid-19 induced respiratory distress
By IPP Bureau - September 22, 2021
Ampion is directly administered by inhalation and it allows the drug to directly target and attenuate inflammation in the lungs
Trivitron launches SpaceD radiation protection aprons
By IPP Bureau - September 22, 2021
These aprons utilise phase change materials that absorb, store and release heat for optimal thermal comfort
MetroMedi ties up with BMS Fit Club for diabetes management
By IPP Bureau - September 22, 2021
The consultations are virtual and they have launched the Diabetes Reversal Programme to address the issue
Zydus agrees to sell Mifegest and Cytolog to Integrace
By IPP Bureau - September 21, 2021
The purchaser is a part of the portfolio companies of PE firm True North. The said transaction is not a related party transaction.
AYUSH minister Sonowal exhorts researchers to explore Indian traditional medicine
By IPP Bureau - September 21, 2021
Assam is home to more than 1,700 species of medicinal plants
U.S. FDA approves Samsung Bioepis and Biogen’s BYOOVIZ biosimilar
By IPP Bureau - September 21, 2021
It becomes the first ophthalmology biosimilar to gain FDA approval in the United States
HUTCHMED initiates a Japan bridging study to Support Surufatinib
By IPP Bureau - September 21, 2021
Surufatinib is the third potential new medicine discovered by the company to enter into clinical development in Japan
Pfizer and BioNTech’s Covid-19 vaccine safe for children aged 5 to 11: study
By IPP Bureau - September 21, 2021
In participants 5 to 11 years of age, the vaccine was safe, well-tolerated and showed robust neutralising antibody responses. Results in children under 5 years of age are expected as soon as later this year
